Literature DB >> 20008776

Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.

Anna Fàbrega1, Robert G Martin, Judah L Rosner, M Mar Tavio, Jordi Vila.   

Abstract

Elevated levels of fluoroquinolone resistance are frequently found among Escherichia coli clinical isolates. This study investigated the antibiotic resistance mechanisms of strain NorE5, derived in vitro by exposing an E. coli clinical isolate, PS5, to two selection steps with increasing concentrations of norfloxacin. In addition to the amino acid substitution in GyrA (S83L) present in PS5, NorE5 has an amino acid change in ParC (S80R). Furthermore, we now find by Western blotting that NorE5 has a multidrug resistance phenotype resulting from the overexpression of the antibiotic resistance efflux pump AcrAB-TolC. Microarray and gene fusion analyses revealed significantly increased expression in NorE5 of soxS, a transcriptional activator of acrAB and tolC. The high soxS activity is attributable to a frameshift mutation that truncates SoxR, rendering it a constitutive transcriptional activator of soxS. Furthermore, microarray and reverse transcription-PCR analyses showed that mdtG (yceE), encoding a putative efflux pump, is overexpressed in the resistant strain. SoxS, MarA, and Rob activated an mdtG::lacZ fusion, and SoxS was shown to bind to the mdtG promoter, showing that mdtG is a member of the marA-soxS-rob regulon. The mdtG marbox sequence is in the backward or class I orientation within the promoter, and its disruption resulted in a loss of inducibility by MarA, SoxS, and Rob. Thus, chromosomal mutations in parC and soxR are responsible for the increased antibiotic resistance of NorE5.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008776      PMCID: PMC2825980          DOI: 10.1128/AAC.00944-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.

Authors:  Mark A Webber; Ashraf Talukder; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli.

Authors:  J A Fralick
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

3.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.

Authors:  H Okusu; D Ma; H Nikaido
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

5.  Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates.

Authors:  Anastasia Koutsolioutsou; Samuel Peña-Llopis; Bruce Demple
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals.

Authors:  D Ma; M Alberti; C Lynch; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1996-01       Impact factor: 3.501

7.  Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.

Authors:  M Oethinger; I Podglajen; W V Kern; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.

Authors:  J Vila; J Ruiz; P Goñi; M T De Anta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Purification and regulatory properties of MarA protein, a transcriptional activator of Escherichia coli multiple antibiotic and superoxide resistance promoters.

Authors:  K W Jair; R G Martin; J L Rosner; N Fujita; A Ishihama; R E Wolf
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

10.  Glutathione-mediated destabilization in vitro of [2Fe-2S] centers in the SoxR regulatory protein.

Authors:  H Ding; B Demple
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  16 in total

1.  Promoter discrimination at class I MarA regulon promoters mediated by glutamic acid 89 of the MarA transcriptional activator of Escherichia coli.

Authors:  Robert G Martin; Judah L Rosner
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

2.  Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli Strains clinically isolated from urinary tract infection patients.

Authors:  Tomihiko Yasufuku; Katsumi Shigemura; Toshiro Shirakawa; Minori Matsumoto; Yuzo Nakano; Kazushi Tanaka; Soichi Arakawa; Shouhiro Kinoshita; Masato Kawabata; Masato Fujisawa
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

3.  Reduction of cellular stress by TolC-dependent efflux pumps in Escherichia coli indicated by BaeSR and CpxARP activation of spy in efflux mutants.

Authors:  Judah L Rosner; Robert G Martin
Journal:  J Bacteriol       Date:  2012-12-21       Impact factor: 3.490

4.  Membrane stresses induced by overproduction of free fatty acids in Escherichia coli.

Authors:  Rebecca M Lennen; Max A Kruziki; Kritika Kumar; Robert A Zinkel; Kristin E Burnum; Mary S Lipton; Spencer W Hoover; Don R Ranatunga; Tyler M Wittkopp; Wesley D Marner; Brian F Pfleger
Journal:  Appl Environ Microbiol       Date:  2011-09-23       Impact factor: 4.792

Review 5.  Iron-containing transcription factors and their roles as sensors.

Authors:  Angela S Fleischhacker; Patricia J Kiley
Journal:  Curr Opin Chem Biol       Date:  2011-02-01       Impact factor: 8.822

6.  Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.

Authors:  Johannes Camp; Sabine Schuster; Martina Vavra; Tobias Schweigger; John W A Rossen; Sandra Reuter; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

7.  Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae.

Authors:  Astrid Pérez; Margarita Poza; Jesús Aranda; Cristina Latasa; Francisco Javier Medrano; María Tomás; Antonio Romero; Iñigo Lasa; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

8.  Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages.

Authors:  Ayari Fuentes-Hernandez; Jessica Plucain; Fabio Gori; Rafael Pena-Miller; Carlos Reding; Gunther Jansen; Hinrich Schulenburg; Ivana Gudelj; Robert Beardmore
Journal:  PLoS Biol       Date:  2015-04-08       Impact factor: 8.029

9.  Virulence and transcriptome profile of multidrug-resistant Escherichia coli from chicken.

Authors:  Hafiz I Hussain; Zahid Iqbal; Mohamed N Seleem; Deyu Huang; Adeel Sattar; Haihong Hao; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

10.  Identification of transport proteins involved in free fatty acid efflux in Escherichia coli.

Authors:  Rebecca M Lennen; Mark G Politz; Max A Kruziki; Brian F Pfleger
Journal:  J Bacteriol       Date:  2012-10-26       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.